Results 251 to 260 of about 87,827 (343)

Hearing Loss in Leucine-Rich Glioma-Inactivated 1 Encephalitis: Cochlear Implantation Considerations. [PDF]

Cureus
Saleem N, Robbins M, Foster J, Kelley B.
europepmc   +1 more source

Sensorineural Deafness and MMR Immunization

, 1993
J Gordon Millichap
openalex   +2 more sources

Congenital Disorder of Glycosylation Following ATP6AP1 Deficiency With Normal Liver Function: A Case Report

Clinical Case Reports, Volume 13, Issue 9, September 2025.
ABSTRACT Congenital disorders of glycosylation (CDG) are a heterogeneous group of inherited metabolic diseases (IMD) characterized by defects in the synthesis and modification of glycoproteins and glycolipids. One of these disorders is ATP6AP1‐CDG, a rare X‐linked disease with approximately 30 cases reported so far. Symptoms associated with ATP6AP1‐CDG
Amirreza Jabbaripour Sarmadian, Babak Abdinia, Kia Seyed Toutounchi, Mohammad Saberi, Shabnam Eskandarzadeh   +4 more
wiley   +1 more source

Hypergonadotropic Hypogonadism, Progressive Early-Onset Spinocerebellar Ataxia, and Late-Onset Sensorineural Hearing Loss: Case Report and Literature Review

Balkan Journal of Medical Genetics, 2011
Sarikaya E, Ensert C, Gulerman H
doaj   +1 more source

Cochlear implant in type 2 neurofibromatosis: an option for better hearing rehabilitation Implante coclear em neurofibromatose tipo 2: uma opção para melhor reabilitação auditiva

Brazilian Journal of Otorhinolaryngology, 2011
Oswaldo Laércio M Cruz, Eduardo A. S Vellutini   +1 more
doaj   +1 more source

Cochlear implantation in children with Bartter syndrome: A case report. [PDF]

Sci Prog
Badr KM, Raza SA, Alahmadi A, Alghamdi F, Thabet AM, Alghamdi S.   +5 more
europepmc   +1 more source

When a Threat is Not a Threat: Why Persons Who Are Deaf or Hard of Hearing Are Left Unprotected by California Penal Code Section 422 and How the Courts Could Rectify It [PDF]

, 2011
Greer, Benjamin Thomas, Modell, Scott J.
core   +2 more sources

Combined Immediate‐Release and Extended‐Release Formulation of Sodium Valproate Provides Stable Plasma Levels for Inhibition of Histone Deacetylation

Clinical Pharmacology in Drug Development, Volume 14, Issue 9, Page 717-727, September 2025.
Abstract A modified controlled‐release sodium valproate formulation (VAL001, test) was compared with an approved enteric‐coated tablet formulation (Absenor, reference). Pharmacokinetics and safety/tolerability were evaluated in healthy subjects to bridge with positive efficacy results from an early‐phase patient trial of valproate in combination with ...
Nikhil Ahuja, Susanna Kääriäinen, Zsófia Lovró, Mia Lundblad, Kristina Drott, Elsa Lilienberg, Marica T. Engström, Karla Saukkonen, Mika Scheinin   +8 more
wiley   +1 more source

Communicating Hydrocephalus After Radiotherapy for a Vestibular Schwannoma. [PDF]

Cureus
Set HHM, Sann KN, Shanmugasundaram R.
europepmc   +1 more source